Abivax SA, a French company, is conducting clinical trials in the US and seeking alignment on NDA submission strategy with the FDA.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Abivax SA, a French company, is conducting clinical trials in the US and seeking alignment on NDA submission strategy with the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Marc de Garidel
French businessman
Nothing else this week.
- FDA
Related events
- Lakefront, in collaboration with Gilead, received Orphan Drug Designation from the FDA for gamgertamig, with trials active globally.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.
- Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.
- Data was presented in Athens supporting a future U.S. NDA submission to the FDA.